ArticleBritish journal of clinical pharmacology2015

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.

Katalin Monostory et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.